Histological characteristics of primary biliary cholangitis in patients with incomplete responses to ursodeoxycholic acid

Liver histology in patients with incomplete responses to UDCA is characterized predominantly by advanced disease features, including severe hepatitis, bile duct loss, and orcein-positive granule deposition, rather than by fibrosis alone. The Nakanuma classification offers a more accurate evaluation of disease severity compared to conventional classifications. These histological findings provide valuable insights for interpreting the outcomes of recent clinical trials of second-line therapies for PBC, particularly those targeting immune-mediated mechanisms.

Authors

Institutions

Publication Details

Journal
Human Pathology
Published
2025-10-22
DOI
https://doi.org/10.1016/j.humpath.2025.105957
Citations
1
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
1.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Histological characteristics of primary biliary cholangitis in patients with incomplete responses to ursodeoxycholic acid

Seiichiro Hojo, Yasuni Nakanuma, Kenichi Harada, Shinji Shimoda et al.
1 citations
Human Pathology
Liver Diseases and Immunity
1.32
article

Histological characteristics of primary biliary cholangitis in patients with incomplete responses to ursodeoxycholic acid

Seiichiro Hojo, Yasuni Nakanuma, Kenichi Harada, Shinji Shimoda, Hirohito Tsubouchi, Hitoshi Yoshiji, Yuko Kakuda, Toshio Imai, Masanori Abe, Hiromasa Ohira, Mikio Zeniya, Tadashi Namisaki, Tetsu Kawano, Atsushi Tanaka, Atsushi Umeda, Yukari Higashine, Yuki Kamiya, Akio Ido
article en
1 citations

Abstract

Liver histology in patients with incomplete responses to UDCA is characterized predominantly by advanced disease features, including severe hepatitis, bile duct loss, and orcein-positive granule deposition, rather than by fibrosis alone. The Nakanuma classification offers a more accurate evaluation of disease severity compared to conventional classifications. These histological findings provide valuable insights for interpreting the outcomes of recent clinical trials of second-line therapies for PBC, particularly those targeting immune-mediated mechanisms.

Human PathologyVol. 166
Kanazawa University (JP), Kagoshima University (JP), Kansai Medical University (JP), Fukushima Medical University (JP), Kobe Institute Of Computing (JP), Shizuoka Cancer Center (JP), KAN Research Institute (JP), Kagoshima City Hospital (JP), Fukui-ken Saiseikai Hospital (JP), EA Pharma (Japan) (JP), Ehime University (JP), Eisai (Japan) (JP), Nara Medical University (JP), International University of Health and Welfare (JP), Teikyo University (JP)
Openalex Percentile: Top 15%
Liver Diseases and Immunity
1.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.